Shuainan Ma Selected Research

p38 Mitogen-Activated Protein Kinases

7/2015

Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuainan Ma Research Topics

Disease

2	Cognitive Dysfunction 01/2024 - 01/2017
1	Cerebral Hemorrhage 12/2023
1	Pathologic Processes 12/2023
1	Neuroinflammatory Diseases 12/2023
1	Brain Injuries (Brain Injury) 12/2023
1	Inflammation (Inflammations) 12/2023
1	Experimental Autoimmune Neuritis 07/2015
1	Brain Infarction 04/2013
1	Infarction (Infarctions) 04/2013
1	Ischemic Stroke 04/2013
1	Cerebral Infarction 04/2013

Drug/Important Bio-Agent (IBA)

2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2024 - 01/2017
1	InflammasomesIBA 01/2024
1	Protein Kinases (Protein Kinase)IBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	NF-kappa B (NF-kB)IBA 12/2023
1	SB 203580IBA 07/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2015
1	p38 Mitogen-Activated Protein KinasesIBA 07/2015
1	CytokinesIBA 04/2013
1	InterleukinsIBA 04/2013
1	Interleukin-17 (Interleukin 17)IBA 04/2013
1	EnzymesIBA 04/2013
1	ImmunosorbentsIBA 04/2013
1	Interleukin-23 (Interleukin 23)IBA 04/2013
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2013

Therapy/Procedure

1	Transplantation 04/2013